We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+18.86%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$263M
Cap. Flow
+$161M
Cap. Flow %
15.05%
Top 10 Hldgs %
38.19%
Holding
78
New
29
Increased
11
Reduced
16
Closed
18

Top Buys

Rank Stock Value
1
SAIC icon
Saic
SAIC
+$45.2M
2
BERY
Berry Global Group, Inc.
BERY
+$35.7M
3
STML
Stemline Therapeutics, Inc.
STML
+$34M
4
TSN icon
Tyson Foods
TSN
+$26.7M
5
ENOV icon
Enovis
ENOV
+$25.8M

Top Sells

Rank Stock Value
1
INCY icon
Incyte
INCY
+$42.9M
2
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$39.1M
3
HRTX icon
Heron Therapeutics
HRTX
+$33.7M
4
PRTY
Party City Holdco Inc.
PRTY
+$25.1M
5
AGO icon
Assured Guaranty
AGO
+$22.1M

Sector Composition

Rank Sector Weight
1 Healthcare 38.78%
2 Technology 13.01%
3 Industrials 11.63%
4 Materials 8.42%
5 Financials 7.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRSP
26
DELISTED
Perspecta Inc. Common Stock
PRSP
$18.2M 1.7%
900,000
+501,920
+126% +$10.1M
HGV icon
27
Hilton Grand Vacations
HGV
$3.34B
$17.6M 1.65%
572,104
+84,884
+17% +$2.6M
CSTM icon
28
Constellium
CSTM
$4.05B
$15.3M 1.43%
1,917,813
-106,787
-5% -$912K
SAVE
29
DELISTED
Spirit Airlines, Inc.
SAVE
$15.1M 1.41%
+285,000
New +$16.4M
MDR
30
CALL
DELISTED
McDermott International
MDR
$13.1M 1.22%
+1,760,700
New +$14.5M
JBLU icon
31
JetBlue
JBLU
$2.19B
$12.2M 1.14%
+743,486
New +$12.7M
BDSI
32
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$12.1M 1.13%
2,292,132
+296,173
+15% +$1.35M
SMTA
33
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
$12M 1.12%
1,841,587
– –
DAL icon
34
Delta Air Lines
DAL
$59.5B
$10.3M 0.96%
+199,924
New +$9.92M
AGN
35
DELISTED
Allergan plc
AGN
$10.3M 0.96%
+70,400
New +$10.2M
SAFM
36
DELISTED
Sanderson Farms Inc
SAFM
$10.2M 0.95%
+77,337
New +$9.26M
STNG icon
37
Scorpio Tankers
STNG
$3.72B
$9.92M 0.93%
+500,000
New +$9.48M
PPC icon
38
Pilgrim's Pride
PPC
$6.4B
$9.46M 0.88%
+424,405
New +$8.33M
LSAK icon
39
Lesaka Technologies
LSAK
$414M
$9.2M 0.86%
+2,562,200
New +$10.6M
FLXN
40
DELISTED
Flexion Therapeutics, Inc.
FLXN
$8.96M 0.84%
718,307
– –
MGY icon
41
Magnolia Oil & Gas
MGY
$6.16B
$8.91M 0.83%
742,477
– –
VKTX icon
42
Viking Therapeutics
VKTX
$3.94B
$8.05M 0.75%
+810,000
New +$6.78M
AERI
43
DELISTED
Aerie Pharmaceuticals
AERI
$7.79M 0.73%
164,070
-398,115
-71% -$17.5M
SEB icon
44
Seaboard Corp
SEB
$3.99B
$7.13M 0.67%
+1,663
New +$6.41M
I
45
DELISTED
INTELSAT S. A.
I
$5.87M 0.55%
+374,641
New +$7.95M
MUR icon
46
Murphy Oil
MUR
$5.12B
$5.86M 0.55%
+200,000
New +$5.67M
WKC icon
47
World Kinect Corp
WKC
$1.88B
$5.77M 0.54%
+199,658
New +$5.24M
MGNX icon
48
MacroGenics
MGNX
$249M
$5.07M 0.47%
+282,200
New +$4.88M
FOLD
49
DELISTED
Amicus Therapeutics
FOLD
$4.96M 0.46%
+365,000
New +$4.46M
AKBA icon
50
Akebia Therapeutics
AKBA
$240M
$4.95M 0.46%
604,481
-465,614
-44% -$3.2M
1
2
3 4

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return

Rubric Capital Management (New York)'s Q1 2019 Portfolio in Review

As of Q1 2019, Rubric Capital Management (New York) held 78 positions worth $1.07B, up 33% from $808M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Rubric Capital Management (New York) deployed $161M of net new capital in Q1 2019, opening 29 new positions and adding to 11 existing holdings. Its largest new stake was Saic: 642,053 shares worth $49.4M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 36% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Heron Therapeutics, an estimated $33.7M trimmed.

  • Rubric Capital Management (New York)'s largest Q1 2019 buy was Saic: 642,053 shares worth $49.4M.
  • Rubric Capital Management (New York) added most to Berry Global Group, Inc. in Q1 2019, an estimated $35.7M increase.
  • Rubric Capital Management (New York)'s biggest Q1 2019 reduction was Heron Therapeutics, cutting an estimated $33.7M.
  • Rubric Capital Management (New York) fully exited Incyte in Q1 2019, selling an estimated $42.9M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 38% of its $1.07B portfolio in Q1 2019.
  • Rubric Capital Management (New York) opened 29 new positions and closed 18 in Q1 2019.
  • Rubric Capital Management (New York)'s portfolio value rose 33% quarter-over-quarter to $1.07B.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2019, filed 10 May 2019.